Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Ramsay Generale de Sante (GDS) Stock Price & Analysis

1 Followers

GDS Stock Chart & Stats

€8.70-€0.10(-1.14%)
At close: 5:30 PM GMT+1
€9€10€11Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
EUR 8.54 - EUR 8.86
52-Week Range
EUR 8.50 - EUR 11.55
Previous Close
EUR 8.80
Volume
N/A
Average Volume (3M)
937
Market Cap
EUR 971.18M
Enterprise Value
EUR 5.03B
Total Cash (Recent Filing)
EUR 302.20M
Total Debt (Recent Filing)
EUR 4.03B
Price to Earnings (P/E)
―
Beta
0.14
Next Earnings
Feb 24, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Dec 02, 2014
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Stable Gross Margins

Gross margins of roughly 78%–80% have remained very strong and stable, indicating substantial gross-profit retention within the care-facilities model. This provides a durable economic base to absorb operating pressures and potentially support recovery if revenue performance improves.

Positive Cash Generation

Operating cash flow has remained positive and free cash flow was positive in every year shown, including 2024–2026. This recurring internal cash generation supports ongoing operations and gives management some capacity to invest or reduce debt, despite recent volatility.

Prior Revenue Expansion

Revenue expanded steadily from 2021–2025 before the latest contraction, showing that the company had demonstrated multi-year ability to grow its hospital and clinic revenue base. That prior trajectory is a constructive foundation if recent pressure proves reversible.

Bears Say

Sharp Revenue Contraction

Latest annual revenue fell 32.8%, materially interrupting the prior multi-year expansion. A contraction of this scale can weaken operating leverage, reduce resources available for reinvestment, and make a return to sustained earnings growth more difficult over the next several quarters.

Recurring Net Losses

Net results were consistently negative in 2024–2026 after positive net income in 2021–2023, while ROE also turned negative. Persistent bottom-line losses erode shareholder returns and can constrain reinvestment, financial flexibility, and the ability to benefit from otherwise strong gross margins.

High Leverage

Debt stood at roughly 3.3x–3.6x equity, equity drifted down, and recent cash-flow coverage of total debt was only about 0.34–0.43. This combination leaves less flexibility to absorb earnings volatility, fund growth, or reduce leverage quickly when performance is weak.

Ramsay Generale de Sante News

GDS FAQ

What was Ramsay Generale de Sante’s price range in the past 12 months?
Ramsay Generale de Sante lowest stock price was €8.50 and its highest was €11.55 in the past 12 months.
What is Ramsay Generale de Sante’s market cap?
Ramsay Generale de Sante’s market cap is €971.18M.
When is Ramsay Generale de Sante’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Ramsay Generale de Sante’s earnings last quarter?
Ramsay Generale de Sante released its earnings results on Aug 26, 2026. The company reported -€0.121 earnings per share for the quarter.
Is Ramsay Generale de Sante overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Ramsay Generale de Sante pay dividends?
Ramsay Generale de Sante pays a semiannual dividend of €0.791 which represents an annual dividend yield of ―. See more information on Ramsay Generale de Sante dividends here
What is Ramsay Generale de Sante’s EPS estimate?
Ramsay Generale de Sante’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ramsay Generale de Sante have?
Ramsay Generale de Sante has 110,389,690 shares outstanding.
What happened to Ramsay Generale de Sante’s price movement after its last earnings report?
Ramsay Generale de Sante reported an EPS of -€0.121 in its last earnings report. Following the earnings report the stock price went down -0.696%.
Which hedge fund is a major shareholder of Ramsay Generale de Sante?
Currently, no hedge funds are holding shares in FR:GDS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology